Analysis of Novel Positioning Sensor-assisted Postoperative Position Correction and Effective Prone Time Recorded in Patients With Different Prone Times After Macular Hole Surgery

Sponsor
Tianjin Medical University Eye Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05757349
Collaborator
(none)
86
1
2
17.9
4.8

Study Details

Study Description

Brief Summary

Idiopathic macular hole (IMH) is a fundus disease without clear etiology, most often seen in healthy women over 50 years of age, and is often associated with ocular manifestations such as loss of central vision and visual distortion. It is often associated with loss of central vision, visual distortion, and other ocular manifestations. It is currently treated by vitrectomy combined with internal limiting membranes (ILM) peeling followed by gas filling. A strict prone position for a certain period of time after surgery has a positive effect on the healing of the macular fissure. The need for a strict prone position after IMH has been demonstrated in previous studies (especially when the IMH diameter is >400 μm). However, due to the anti-human mechanics of the face-down position, patient comfort, sleep quality and quality of life are greatly compromised. Therefore, this study designed a smart head position monitoring device to assist patients in maintaining the correct position and recording the effective position time. The study was conducted to determine the shortest prone position time based on macular fissure closure, to minimize the adverse effects of postoperative position, and to obtain the maximum recovery of visual acuity and visual field.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Face-down position time 1-day
  • Behavioral: Face-down position time 3-day
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Prospective Study on the Prognosis of the Idiopathic Macular Hole With Different Prone Position Times Assisted by Novel Positioning Sensor
Actual Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Mar 30, 2024
Anticipated Study Completion Date :
Mar 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Face-down position time 1-day group

Postoperative face-down position of subjects wearing the novel positioning sensor device for 1-day.

Behavioral: Face-down position time 1-day
Postoperative face-down position of subjects wearing the novel positioning sensor device for 1-day.

Active Comparator: Face-down position time 3-day group

Postoperative face-down position of subjects wearing the novel positioning sensor device for 3-day.

Behavioral: Face-down position time 3-day
Postoperative face-down position of subjects wearing the novel positioning sensor device for 3-day.

Outcome Measures

Primary Outcome Measures

  1. Macular hole closure rate [6 month postoperatively]

    Ratio of patients with postoperative lacunae that remained closed until the end of the follow-up time to the number of patients who reopened during the follow-up time of those who did not close after surgery

  2. Effective face-down position time [1 or 3 day postoperatively]

    Novel positioning sensor related data cloud storage platform can record and extract effective face-down position time.

Secondary Outcome Measures

  1. Best corrected visual acuity change (BCVA) [1, 3, 6 month postoperatively]

    BCVA for patients after macular fissure surgery, expressed using the (ETDRS) Alphabet Chart.

  2. Retinal nerve fiber layer thickness change [1, 3, 6 month postoperatively]

    Three-dimensional spectral domain optical coherence tomography (SD-OCT)

  3. Macular ganglion cell complex thickness change (GCL+, GCL++) [1, 3, 6 month postoperatively]

    Three-dimensional spectral domain optical coherence tomography (SD-OCT)

  4. Mean retinal Sensitivity (MS) [1, 3, 6 month postoperatively]

    Micro Perimeter 3

  5. Central 2˚ and 4˚ fixation [1, 3, 6 month postoperatively]

    Micro Perimeter 3

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged 18 years or older;

  • Patients diagnosed with IMH;

  • Patients requiring face-down position after vitrectomy combined with ILM peeling and C3F8(14%) gas filling; Tolerated face-down position after surgery;

  • Agreed to the study protocol.

Exclusion Criteria:
  • Myopia greater than or equal to -6.0 D; Eye axis length (AL) greater than 26.0mm;

  • Trauma, macular edema, macular degeneration, and other secondary MH with clear etiology;

  • Previous history of internal eye surgery in the operated eye;

  • Patients with local or systemic other diseases significantly affecting visual function;

  • Those who cannot maintain face-down position after surgery due to systemic factors, etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tianjin medical university eye hosipital Tianjin Tianjin China

Sponsors and Collaborators

  • Tianjin Medical University Eye Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bojie Hu, Professor, Tianjin Medical University Eye Hospital
ClinicalTrials.gov Identifier:
NCT05757349
Other Study ID Numbers:
  • TianjinMUEHhbj456
First Posted:
Mar 7, 2023
Last Update Posted:
Mar 7, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 7, 2023